MPO and COVID-19: In addition, in the presence of flutamide, the number of MPO-positive neutrophils remained at the basal level in the male patients with COVID-19; in contrast, at the highest concentration of PMA (100 ng/mL), flutamide significantly reduced the number of MPO-positive neutrophils (from 51% to 37%, p = 0.019).